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COMMENTARY
Individualized real-time clinical 
decision support to monitor cardiac loading 
during venoarterial ECMO
Michael Broomé1,2,3*  and Dirk W. Donker4
Abstract 
Veno-arterial extracoporeal membrane oxygenation (VA ECMO) is increasingly used for acute and refractory cardio-
genic shock. Yet, in clinical practice, monitoring of cardiac loading conditions during VA ECMO can be cumbersome. 
To this end, we illustrate the validity and clinical applicability of a real-time cardiovascular computer simulation, which 
allows to integrate hemodynamics, cardiac dimensions and the corresponding degree of VA ECMO support and ven-
tricular loading in individual patients over time.
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Background
With great interest we read the recent publication by 
Ostadal et  al. Their experimental work underscores the 
clinical relevance to closely monitor left-ventricular 
(LV) loading conditions in cardiogenic shock supported 
by venoarterial extracorporeal membrane oxygenation 
(VA ECMO) [1]. They report on significant negative 
influences on intrinsic cardiac output, left ventricular 
performance and stroke work as a result of increasing 
extracorporeal blood flow intended to maximally support 
the circulation in cardiogenic shock. It is increasingly 
recognized that LV overloading during VA ECMO may 
cumulate in feared complications as pulmonary edema, 
acute lung injury after ‘bridge–bridge’ strategies and even 
progression to irreversible myocardial damage, all hav-
ing significant impact on outcome [2–5]. Yet, in clini-
cal practice, it can be challenging to provide adequate 
systemic perfusion, while equally addressing favourable 
LV loading conditions. The practical difficulties to opti-
mally tailor VA ECMO may be improved by a bedside 
monitoring tool that allows instantaneous integration 
of patient-specific data on cardiac dimensions, hemo-
dynamics, fluid loading and pharmacotherapy with the 
degree of circulatory VA ECMO support.
Methods and results
In order to enhance bedside clinical decision support, we 
introduced a real-time, patient-specific simulation model 
of cardiovascular dynamics [6, 7]. The model is built with 
32 0-D compartments in total; four cardiac chambers, 
pericardium, intrathoracic space and 27 vascular com-
partments including systemic circulation, pulmonary 
circulation and coronary circulation. Pressures, volumes, 
flows and oxygen saturations are updated with 4000 Hz 
in all compartments by numerical solution of differential 
equations with parameters based on physical dimensions 
of each compartment. In addition ECMO flow is simu-
lated by connection of a virtual centrifugal pump to vas-
cular compartments in the model. This approach allowed 
us to reproduce the experimental results published by 
Ostadal et al. [1] using their experimental baseline char-
acteristics on hemodynamics and cardiac dimensions as 
input parameters for the computer model assuming a 
constant systemic vascular resistance (SVR). The simula-
tion rendered output data in agreement with the original 
experimental data (Fig. 1). As a next step, we translated 
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which allowed us to integrate individual patient data 
into the simulation model: a 35 year-old female without 
any medical history complained of palpitations, aspe-
cific chest pain and progressive dyspnea 2 weeks prior to 
admission. After progressive clinical deterioration, she 
presented in acute and severe cardiogenic shock refrac-
tory to conventional management, i.e., adequate fluid 
loading and inotropics (i.v. Milrinone 0,1 μg/kg/min; nor-
epinephrine 300  μg/kg/min) and was therefore urgently 
supported by bi-femoral (17F, 21F) VA ECMO (Rotaflow 
PLS, MAQUET, Cardiopulmonary AG, Hirrlingen, Ger-
many). Diagnostic work-up revealed acute myocarditis 
as proven by right-ventricular endomyocardial biopsies. 
After initiation of immunosuppressive therapy (meth-
ylprednisolone) she was successfully weaned from VA 
ECMO after 3  days. Serial echocardiograms were per-
formed in order to derive cardiac dimensions accord-
ing to international standards [8]. Simultaneously, heart 
rate, central venous pressure, arterial blood pressure, 
details on pharmacological management and VA ECMO 
support were recorded. Clinical echocardiograms and 
simulated pressure–volume (PV) loops corresponding 
to the clinical states are shown in Fig. 2 and available as 
Additional files 1: Echocardiogram before ECMO and 2: 
Echocardiogram on ECMO. The physiological effect of 
only increasing ECMO flow on ventricular PV loops is 
shown in Fig. 3. Animations of simulations are also avail-
able as Additional files 3: Simulation of Ostedal VAE-
CMO experiment and 4: Simulation of clinical VAECMO 
case.  
Discussion
The experimental data by Ostadal et  al. are in agreement 
with our clinical translation enhanced by real-time car-
diovascular simulation, both demonstrating unsatisfac-
tory LV unloading during high-flow VA ECMO (Table 1). 
Importantly, the simulation points to a causal direct 
hemodynamic effect of VA ECMO on increased LV pre- 
and afterload as a function of augmented extracorporeal 
support. Alternative mechanistic explanations as valvu-
lar regurgitation, venous bronchial circulation, coronary 
ischemia or vegetative influences as suggested by Ostadal 
Fig. 1 Comparison of hemodynamic variables in experimental study 
and simulation with ECMO flow 1–5 L/min. Heart rates are identical 
(input data). Systolic pressure increase is larger in the experiment. Car-
diac output, left ventricular volumes and ejection fraction are almost 
identical. Comparison of experimental and simulated data sug-
gests an increase in systemic vascular resistance in the experiment, 
whereas resistance was assumed to be unchanged in the simulation
◂
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et al. seem less likely as significant contributors since these 
phenomena are not incorporated in the current simulations 
generating results in agreement with the experimental 
data. Moreover, LV dilatation and increase of end-diastolic 
pressure occur in the model despite a constant SVR and 
a less pronounced increase in systolic arterial pressure 
Fig. 2 Comparison of end-diastolic transthoracic echocardiograms in upper panel shows dilatation of the left ventricle after initiation of VA ECMO 
(right) as compared to baseline before initiation of VA ECMO (left). The lower panel shows simulated left (black) and right (gray) ventricular pressure–
volume loops before (left lower) and after adjustment of heart rate, systemic vascular resistance and absence of tricuspid regurgitation (right lower) 
in accordance with available clinical data
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as compared to the experiments. The steep increase in 
arterial pressures and stroke work found experimentally 
while applying high flow is likely explained not only by an 
increase in systemic blood flow (due to ECMO) but also 
by an increase in SVR not commented by the authors. 
This increase in SVR in the experiment may be explained 
by myogenic vascular autoregulation or altered anesthetic 
depth. The clinical relevance of our findings to strive for 
patient-specific tailoring towards reduced VA ECMO 
flow in order to optimize LV loading conditions is under-
scored by a report that extracorporeal support flow <60 % 
of the theoretical individual requirement has been associ-
ated with superior clinical outcome in VA ECMO, while 
accounting for both adequate systemic perfusion and LV 
ejection avoiding additional measures of LV venting [5].
Conclusion
Real-time cardiovascular computer modeling allows to 
simulate complex patient-specific clinical scenario’s as in 
extracorporeal support. Our findings support the notion 
that VA-ECMO flow should be maintained as low as pos-
sible in order to balance the simultaneous need of circu-
latory support and LV unloading.
Fig. 3 Effects of simulated increase of VA-ECMO from 0 to 2.1 L/
min left (black) and right (gray) ventricular pressure–volume loops. 
All other model parameters such as cardiac contractility, intravascu-
lar blood volume, systemic and pulmonary vascular resistance are 
unchanged. The results indicate an increase in left ventricular loading, 
that is represented by movement of loops upward (higher pressures) 
and rightward (higher volumes)
Table 1 Comparison of clinical and simulated hemodynamic data before (two left columns) and the first day after initia-
tion of VA-ECMO (two right columns)
The middle column +ECMO only shows effects of solely increasing peripheral ECMO flow from 0 to 2.1 L/min. Simulated data concerning the first day on VA ECMO are 
adjusted according to clinical data (HR identical, SVR and PVR decreased proportionally to achieve identical MAP, TR removed). Simulation supports the experimental 
findings of increased LV loading with VA-ECMO. The larger LV and EF in the patient on the first day of VA ECMO is compatible with fluid loading and partial recovery of 
LV function in addition to the effects of VA-ECMO as supported by clinical data
HR heart rate, SVR systemic vascular resistance, PVR pulmonary vascular resistance, MAP mean arterial pressure, TR tricuspid regurgitation, LV left ventricle and EF 
ejection fraction, NA data are not available
Before ECMO +ECMO only On ECMO first day
Patient Simulation Simulation Patient Simulation
Heart rate /min 137 137 137 133 133
Mean arterial pressure mmHg 85 85 106 98 98
Right ventricular systolic pressure mmHg 49 49 46 NA 47
Central venous pressure mmHg 10 10 9 8 9
Left Ventricular end‐diastolic volume mL 84.6 84.7 93.3 101.1 93.7
Left ventricular end‐diastolic pressure mmHg NA 19 23 NA 23
Ejection fraction % 27.6 27.8 19.5 30.9 23.4
Tricuspid regurgitation velocity cm/s 311 315 310 NA NA
ECMO flow L/min 0 0 2.1 2.1 2.1
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